the effectiveness of neoadjuvant chemoradiation in patient with pancreatic cancer
Phase 2
Recruiting
- Conditions
- Pancreatic cancer.Malignant neoplasm of pancreas
- Registration Number
- IRCT20170306032913N5
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Patients over the age of 18 to 75 years who have not previously received chemotherapy or radiotherapy in the upper abdomen, ,
acceptable liver, kidney, and lung function, and acceptable CBC diff
the functional status of group 0 or one according to the ECOG definition.
Patient with borderline and unresectable nonmetastatic pancreatic cancer
Exclusion Criteria
Serious concomitant systemic disorder
Women with a positive pregnancy test or lactating
Previously radiotherapy of upper abdomen
Have endocrine pancreatic tumors or ampullary cancer
Pathology other than pancreatic adenocarcinoma
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of negative surgical margin. Timepoint: the end of neoadjuvant therapy. Method of measurement: pathological evaluation.
- Secondary Outcome Measures
Name Time Method